Homebiotech

biotech

biotech

New phase 1 data show potential for neurodegenerative disease treatment

Jim Cornall - July 16, 2026

biotech

Metabolic syndrome linked to faster brain ageing

Jim Cornall - July 16, 2026

biotech

Bowel cancer samples could boost understanding of other killer diseases

Jim Cornall - July 16, 2026

biotech

FDA clearance for non-muscle invasive bladder cancer treatment

Jim Cornall - July 15, 2026

biotech

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall - April 9, 2026

biotech

Positive results from moderate-to-severe atopic dermatitis trial

Jim Cornall - April 8, 2026

biotech

Centessa Pharmaceuticals to be acquired by Lilly

Jim Cornall - April 8, 2026

biotech

Smart drugs to fight cancer

Jim Cornall - April 8, 2026

biotech

OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery

Jim Cornall - April 7, 2026

biotech

New biomarker helps assess aggression of glioblastoma

Jim Cornall - April 7, 2026

biotech

Protein helps cancer cells survive treatment

Jim Cornall - April 7, 2026

biotech

Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes

Jim Cornall - April 3, 2026

1...212223...89 Page 22 of 89

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New phase 1 data show potential for neurodegenerative disease treatment

Jim Cornall - July 16, 2026 0

Vandria has presented new data from the multiple ascending dose part of its phase 1 study of VNA-318. The data, presented at the Alzheimer's Association...

Metabolic syndrome linked to faster brain ageing

biotech Jim Cornall - July 16, 2026 0

Bowel cancer samples could boost understanding of other killer diseases

biotech Jim Cornall - July 16, 2026 0

FDA clearance for non-muscle invasive bladder cancer treatment

biotech Jim Cornall - July 15, 2026 0

Scientists uncover genetic clues from tumour-prone reptile that could advance cancer research

biotech Jim Cornall - July 15, 2026 0